Clinical features of pachyvessels associated with polypoidal choroidal vasculopathy in chronic central serous chorioretinopathy

Código QR

Clinical features of pachyvessels associated with polypoidal choroidal vasculopathy in chronic central serous chorioretinopathy

Abstract To investigate the association between clinical features of chronic central serous chorioretinopathy (CSC) and subsequent development of polypoidal choroidal vasculopathy (PCV). Characteristics and treatment response of PCV secondary to CSC were described. This retrospective observational s...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Te-An Wang, Wei-Chun Chan, Shawn H. Tsai, Lee-Jen Chen
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/729a5abc0da346c398a32a7384962031
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Response of serous retinal pigment epithelial detachments to intravitreal aflibercept in polypoidal choroidal vasculopathy refractory to ranibizumab
por: Yamashita M, et al.
Publicado: (2014)

Choroidal excavation with polypoidal choroidal vasculopathy: a case report
por: Kobayashi W, et al.
Publicado: (2012)

Idiopathic polypoidal choroidal vasculopathy in Thai patients with clinical and angiographic choroidal neovascularization
por: Bhoomibunchoo C, et al.
Publicado: (2017)

Choroidal features in flat irregular pigment epithelial detachment associated with Chronic central serous chorioretinopathy: Avascular versus vascularized.
por: Hooshang Faghihi, et al.
Publicado: (2021)

Clinical features and prognosis of polypoidal choroidal vasculopathy with different morphologies of branching vascular network on optical coherence tomography angiography
por: Shang-Te Ma, et al.
Publicado: (2021)

A case of polypoidal choroidal vasculopathy. Periphery is equally important for such patients
por: Dimitrios A Karagiannis, et al.
Publicado: (2009)

Intravitreal aflibercept for polypoidal choroidal vasculopathy after developing ranibizumab tachyphylaxis
por: Miura M, et al.
Publicado: (2013)

Efficacy of intravitreal aflibercept injections for Japanese patients with polypoidal choroidal vasculopathy
por: Arakawa A, et al.
Publicado: (2017)

The characteristics of choriocapillaris flow void in the unilateral polypoidal choroidal vasculopathy fellow eyes
por: Huajui Wu, et al.
Publicado: (2021)

Cost-Utility Analysis of Drug Treatments in Patients with Polypoidal Choroidal Vasculopathy in Thailand
por: Sangroongruangsri S, et al.
Publicado: (2021)

Pattern of presentation of idiopathic polypoidal choroidal vasculopathy in Ibadan, Sub-Saharan Africa
por: Oluleye TS, et al.
Publicado: (2013)

Recurrence and visual prognostic factors of polypoidal choroidal vasculopathy: 5-year results
por: Joo Young Kim, et al.
Publicado: (2021)

Choroidal Remodeling in Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy: A 12-month Prospective Study
por: Daniel Shu Wei Ting, et al.
Publicado: (2017)

Features of emotional and personality status of patients with central serous chorioretinopathy
por: A. A. Shchuko, et al.
Publicado: (2016)

Visual Outcomes and Prognostic Factors of Large Submacular Hemorrhages Secondary to Polypoidal Choroidal Vasculopathy
por: Matsuo Y, et al.
Publicado: (2021)

Two-year follow-up of ranibizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy
por: Nemoto R, et al.
Publicado: (2012)

Polypoidal choroidal vasculopathy (PCV): the 4-year review of the real-life treatment experiences
por: Ratanasukon M, et al.
Publicado: (2018)

Pneumatic displacement with intravitreal bevacizumab for massive submacular hemorrhage due to polypoidal choroidal vasculopathy
por: Kitahashi M, et al.
Publicado: (2014)

Clinical spectrum of severe chronic central serous chorioretinopathy and outcome of photodynamic therapy
por: Mohabati D, et al.
Publicado: (2018)

Central Serous Chorioretinopathy: Pathogenesis and Management
por: Semeraro F, et al.
Publicado: (2019)

Polypoidal Choroidal Vasculopathy Diagnosis and Neovascular Activity Evaluation Using Optical Coherence Tomography Angiography
por: Georges Azar, et al.
Publicado: (2021)

Risk of Recurrence and Transition to Chronic Disease in Acute Central Serous Chorioretinopathy
por: Mohabati D, et al.
Publicado: (2020)

Comparison of visual outcomes between therapy choices and subtypes of polypoidal choroidal vasculopathy (PCV) in Taiwan: a real-world study
por: Ling Yeung, et al.
Publicado: (2021)

Central serous chorioretinopathy: a pathogenetic model
por: et al, et al.
Publicado: (2011)

Treatment of central serous chorioretinopathy with topical NSAIDs
por: Bahadorani S, et al.
Publicado: (2019)

Transpupillary thermotherapy for atypical central serous chorioretinopathy
por: Kawamura R, et al.
Publicado: (2012)

Combined photodynamic therapy and intravitreal bevacizumab for idiopathic polypoidal choroidal vasculopathy: one-year follow-up
por: Mario R Romano, et al.
Publicado: (2010)

One-year results of intravitreal ranibizumab combined with reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy
por: Sakurai M, et al.
Publicado: (2014)

Deep learning and ensemble stacking technique for differentiating polypoidal choroidal vasculopathy from neovascular age-related macular degeneration
por: Yu-Bai Chou, et al.
Publicado: (2021)

Multiple spots of photodynamic therapy for the treatment of severe chronic central serous chorioretinopathy
por: Tsakonas GD, et al.
Publicado: (2012)

Evaluation of Psychophysiological and Hormonal Changes in Acute and Chronic Forms of Central Serous Chorioretinopathy
por: A. A. Shchuko, et al.
Publicado: (2019)

Clinical characteristics and long-term visual outcome of severe phenotypes of chronic central serous chorioretinopathy
por: Mohabati D, et al.
Publicado: (2018)

Systematic review with network meta-analysis of antivascular endothelial growth factor use in managing polypoidal choroidal vasculopathy
por: Sheng-Chu Chi, et al.
Publicado: (2021)

Long-term outcomes of ranibizumab vs. aflibercept for neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
por: Ki Won Jin, et al.
Publicado: (2021)

Low-dose aspirin as treatment for central serous chorioretinopathy
por: Antonio Caccavale, et al.
Publicado: (2010)

Characteristics of intraretinal deposits in acute central serous chorioretinopathy
por: Plateroti AM, et al.
Publicado: (2014)

Oral mineralocorticoid antagonists for recalcitrant central serous chorioretinopathy
por: Chin EK, et al.
Publicado: (2015)

Navigated focal laser photocoagulation for central serous chorioretinopathy
por: Chhablani J, et al.
Publicado: (2014)

Predictive factors of selective mineralocorticoid receptor antagonist treatment in chronic central serous chorioretinopathy
por: Róbert Gergely, et al.
Publicado: (2020)

Changes of outer retinal microstructures after photodynamic therapy for chronic central serous chorioretinopathy
por: Shimizu K, et al.
Publicado: (2017)